The Discounted Cash Flow (DCF) valuation of Avidity Biosciences Inc (RNA) is (75.68) USD. With the latest stock price at 35.58 USD, the upside of Avidity Biosciences Inc based on DCF is -312.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 8.2% | 7.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (254.47) - (44.47) | (75.68) |
| Upside | -815.2% - -225.0% | -312.7% |